Better Cannabis Stock: OrganiGram or Aphria?
Aphria (NYSE: APHA) and OrganiGram (NASDAQ: OGI) are two Canadian cannabis producers that have struggled over the past year. But with Aphria's stock down just 35% and shares of OrganiGram plummeting more than 75%, their paths haven't exactly been similar. OrganiGram's even done considerably worse than the Horizons Marijuana Life Sciences ETF (OTC: HMLSF), which is down 60% over the same period.
Let's take a closer look at these two stocks to see whether the larger decline in price makes OrganiGram a better value buy, or if the divide between the two pot stocks will become even larger this year.
When OrganiGram released its second-quarter results on April 14, the results just weren't good. Not only was net revenue of 23.2 million Canadian dollars down 13.7% from the prior-year period, but the company's loss deepened as well, from CA$6.4 million to CA$6.8 million.
Source Fool.com
